Investor's Calendar

June 2022

Mon Tue Wed Thu Fri Sat Sun
30
31
1
2
3
4
5
 
 
 
 
 
 
 
6
7
8
9
10
11
12
 
 
 
 
 
 
 
13
14
15
16
17
18
19
 
 
 
 
 
 
 
20
21
22
23
24
25
26
 
 
 
 
 
 
 
27
28
29
30
1
2
3
 
 
 
 
 
 
 

Last News

ROVI has obtained the best ESG score from among the 458 companies evaluated in its pharmaceutical subindustry...
2 min
01 Aug, 2022
​ROVI reports operating revenue growth of 31% and net profit growth of 58%
3 min
27 Jul, 2022
EIB and ROVI are signing a EUR 50 million loan agreement in Madrid for research, development and innovation.
4 min
19 Jul, 2022

Information for investors

Marta Campos

Marta Campos

Head of Investor Relations

mcampos@rovi.es

Antonio Marquina

Antonio Marquina

Investor Relations

amarquina@rovi.es

buzón general Rovi

General Email